Patents Assigned to DeuteRx, LLC
  • 3-(SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
    Publication number: 20140288101
    Abstract: The invention provides 3-deuterium-enriched 3-(6-, 7-, or 8-substituted-4-oxoquinazolin-3(4H)-yl)-piperidine-2,6-diones, deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treatment using the same.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 25, 2014
    Applicant: DEUTERX, LLC
    Inventor: Sheila DeWitt
  • 5-DEUTERO-2,4-THIAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
    Publication number: 20140275180
    Abstract: The invention provides 5-deuterium-enriched 2,4-thiazolidinediones (e.g., 5-[4-[2-(5-ethyl-2-pyridyl)-2-oxoethoxy]benzyl]-5-deutero-thiazolidine-2,4-dione), deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treatment using the same.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: DEUTERX, LLC
    Inventor: Sheila DeWitt
  • DEUTERIUM-ENRICHED PIOGLITAZONE
    Publication number: 20140243377
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: May 8, 2014
    Publication date: August 28, 2014
    Applicant: DEUTERX, LLC
    Inventor: Anthony W. Czarnik
  • 3-(5-SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
    Publication number: 20140228382
    Abstract: The invention provides 3-deuterium-enriched 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-piperidine-2,6-diones, deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treatment using the same, such as in the treatment of cancer, an immune-related disease, or an inflammatory disease.
    Type: Application
    Filed: January 14, 2014
    Publication date: August 14, 2014
    Applicant: DEUTERX, LLC
    Inventor: Sheila DeWitt
  • 5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
    Publication number: 20140221369
    Abstract: The invention provides 5-deuterium enriched 2,4-thiazolidinediones and 2,4-oxazolidinediones, such as 5-(4-((6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)benzyl)-5-deutero-thiazolidine-2,4-dione, deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treating medical disorders, such as cancer, using the same.
    Type: Application
    Filed: January 31, 2014
    Publication date: August 7, 2014
    Applicant: DEUTERX, LLC
    Inventor: Sheila DeWitt
  • Deuterium-enriched bupropion
    Patent number: 8735454
    Abstract: The present application describes deuterium-enriched bupropion, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: August 22, 2013
    Date of Patent: May 27, 2014
    Assignee: DeuteRx, LLC
    Inventor: Anthony W. Czarnik
  • Deuterium-enriched pioglitazone
    Patent number: 8722710
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: May 13, 2014
    Assignee: DeuteRx, LLC
    Inventor: Anthony W Czarnik
  • Deuterium-enriched prasugrel
    Patent number: 8669268
    Abstract: The present application describes deuterium-enriched prasugrel, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: March 11, 2014
    Assignee: DeuteRx, LLC
    Inventor: Anthony W Czarnik
  • Deuterium-enriched donepezil
    Patent number: 8669275
    Abstract: The present application describes deuterium-enriched donepezil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: October 3, 2012
    Date of Patent: March 11, 2014
    Assignee: DeuteRx, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED BUPROPION
    Publication number: 20140018436
    Abstract: The present application describes deuterium-enriched bupropion, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2013
    Publication date: January 16, 2014
    Applicant: DEUTERX, LLC
    Inventor: Anthony W. Czarnik
  • Deuterium-enriched bupropion
    Patent number: 8524780
    Abstract: The present application describes deuterium-enriched bupropion, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: May 19, 2010
    Date of Patent: September 3, 2013
    Assignee: DeuteRx, LLC
    Inventor: Anthony W. Czarnik